2 models fit Weave Communications Inc. Common Stock and they agree: 2 of 2 land within 15% of the average. The price is above every model.
Two or more of our models back this value.
Large premium(i)Silver63
Valued as a growth company: Discounted cash flow and P/E comparison.
ACCE opinionWeave Communications Inc. Common Stock (WEAV)
Fair value (2 models)
$4.18
ACCE price target
$7.05
Rating
Overvalued
Horizon
12 months
Fair value published on 18 Oct 2026, 15:06 CEST; previously $3.42 since 9 Oct 2026, 00:00 CEST.
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Rating published on 18 Oct 2026, 15:06 CEST.
Price used: $7.40 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow and P/E comparison.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
77.2% above
-43.6% to fair value
ACCE score
53
out of 100
Analysts
0% buy
4 covering
P/E
0.0x
forward 0.0x
1-year return
+8.0%
Dividend yield
0.00%
Weave Communications Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Weave sells cloud software to healthcare providers, bundling patient communications such as texting, online scheduling, payments and electronic forms into one platform sold mostly to independent practices and specialty clinics. The structural appeal is the 72.4% gross margin, which says the software earns well on each dollar of revenue even though the company is still unprofitable at the operating line, with an operating margin of -6.2% and a return on equity of -25.1%. Revenue is growing 15.5%, so the question for a PM is whether operating leverage can close that gap as the sales base scales, which is the main thing to test on the next few quarterly reports. At a roughly $595M market cap with no index membership, the stock sits outside the bigger passive flows, which can mean less coverage and more price dislocation around earnings. The composite score of 51/100 reflects mixed fundamentals, so this is a name worth a deeper look only if the margin trajectory from here is the thesis you want to underwrite.
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
high
Unprofitable at operating level
Operating margin is -6.2% and net margin -8.0%, with ROE at -25.1%. Earnings growth is 0.0% YoY, so the business is not yet converting its 72.4% gross margin into profit.
moderate
Stock trades above model fair value
The price of $7.40 sits 77.2% above the model fair value of $4.18, and 5.0% above the ACCE price target of $7.05. The valuation case rests on growth assumptions rather than current earnings.
AI research notes
AI-assisted·How I use AIWritten Oct 21, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
Revenue grew 15.5% over the last year, and the company has averaged 24.5% growth per year over five years.
Free cash flow over the last twelve months was $15M, showing the business generates real cash despite reported losses.
The share price of $7.40 sits almost exactly on the analysts' mean price target of $7.40, a sign the market is not pricing in a big drop.
Why it could disappoint
The stock trades 77.2% above the model fair value of $4.18, and the consensus of both valuation models sits below the price.
Net margin of -8.0% and return on equity of -25.1% show the company is still losing money on the capital it uses.
Not one of the 4 analysts rates the stock Buy or Strong Buy, and the diluted share count rose 6.5% last fiscal year.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.
Next results
Oct 29, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
PRO
Ask ACCE
Valuation
INVESTOR
Where WEAV's valuation models land
Price
$7.40
Model fair value
$4.18
Model range
$4.13 to $4.22
Fair value $4.18
Price $7.40
The price is above the whole model range.
Model
Fair value
Upside
Discounted cash flow
P/E comparison
Create a free account: 5 full stock pages a month, no card.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
Quality
INVESTOR
Quality and conviction INVESTOR FEATURE
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
+A plain reason under every score
+Conviction breakdown and growth / value / quality / momentum scores